Henk Doude van Troostwijk

Corporate Officer/Principal presso HANSA BIOPHARMA AB

Health Technology

Consumer Services

Profilo

Henk Doude van Troostwijk is currently the Chief Commercial Officer & Senior VP at Hansa Biopharma AB since 2019.
Prior to this, he worked as the Director-Oncology & Transplantation at Genzyme Europe BV, General Manager-European Commercial Operations at Raptor Pharmaceuticals Corp., and General Manager-European Commercial Operations at Horizon Pharmaceutical LLC.
He holds an MBA degree from Henley Management College.

Posizioni attive di Henk Doude van Troostwijk

Società	Posizione	Inizio
HANSA BIOPHARMA AB	Corporate Officer/Principal	01/06/2019

Tutte le posizioni attive di Henk Doude van Troostwijk

Precedenti posizioni note di Henk Doude van Troostwijk

Società	Posizione	Fine
Raptor Pharmaceuticals Corp. Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007.	Corporate Officer/Principal	-
Genzyme Europe BV Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands.	Corporate Officer/Principal	-
RAPTOR PHARMACEUTICAL CORP	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Henk Doude van Troostwijk

Formazione di Henk Doude van Troostwijk

Henley Management College

Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Henk Doude van Troostwijk

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
HANSA BIOPHARMA AB	Health Technology

Aziende private	3
Raptor Pharmaceuticals Corp. Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007.	Health Technology
Genzyme Europe BV Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands.	Health Technology
Horizon Pharmaceutical LLC Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA.	Health Technology

Vedi le connessioni aziendali